Report Detail

Request for Sample of this report

Pharma & Healthcare Global Sabin Inactivated Polio vaccine (sIPV) Market Growth 2022-2028

  • RnM4439214
    • |
  • 12 May, 2022
    • |
  • Global
    • |
  • 96 Pages
    • |
  • LPI(LP Information)
    • |
  • Pharma & Healthcare

As the global economy mends, the 2021 growth of Sabin Inactivated Polio vaccine (sIPV) will have significant change from previous year. According to our (LP Information) latest study, the global Sabin Inactivated Polio vaccine (sIPV) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Sabin Inactivated Polio vaccine (sIPV) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Sabin Inactivated Polio vaccine (sIPV) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Sabin Inactivated Polio vaccine (sIPV) market, reaching US$ million by the year 2028. As for the Europe Sabin Inactivated Polio vaccine (sIPV) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Sabin Inactivated Polio vaccine (sIPV) players cover Biokangtai, Sinovac, Imbcams, and Intravacc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Sabin Inactivated Polio vaccine (sIPV) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Vials
Syringes

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Biokangtai
Sinovac
Imbcams
Intravacc
Beijing Biological


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Sabin Inactivated Polio vaccine (sIPV) by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Sabin Inactivated Polio vaccine (sIPV) by Country/Region, 2017, 2022 & 2028
  • 2.2 Sabin Inactivated Polio vaccine (sIPV) Segment by Type
    • 2.2.1 Vials
    • 2.2.2 Syringes
  • 2.3 Sabin Inactivated Polio vaccine (sIPV) Sales by Type
    • 2.3.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Type (2017-2022)
  • 2.4 Sabin Inactivated Polio vaccine (sIPV) Segment by Application
    • 2.4.1 Hospitals
    • 2.4.2 Clinics
    • 2.4.3 Others
  • 2.5 Sabin Inactivated Polio vaccine (sIPV) Sales by Application
    • 2.5.1 Global Sabin Inactivated Polio vaccine (sIPV) Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Application (2017-2022)

3 Global Sabin Inactivated Polio vaccine (sIPV) by Company

  • 3.1 Global Sabin Inactivated Polio vaccine (sIPV) Breakdown Data by Company
    • 3.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Annual Sales by Company (2020-2022)
    • 3.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Company (2020-2022)
  • 3.2 Global Sabin Inactivated Polio vaccine (sIPV) Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Company (2020-2022)
    • 3.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Company (2020-2022)
  • 3.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Company
  • 3.4 Key Manufacturers Sabin Inactivated Polio vaccine (sIPV) Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Sabin Inactivated Polio vaccine (sIPV) Product Location Distribution
    • 3.4.2 Players Sabin Inactivated Polio vaccine (sIPV) Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Sabin Inactivated Polio vaccine (sIPV) by Geographic Region

  • 4.1 World Historic Sabin Inactivated Polio vaccine (sIPV) Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Annual Revenue by Geographic Region
  • 4.2 World Historic Sabin Inactivated Polio vaccine (sIPV) Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Annual Revenue by Country/Region
  • 4.3 Americas Sabin Inactivated Polio vaccine (sIPV) Sales Growth
  • 4.4 APAC Sabin Inactivated Polio vaccine (sIPV) Sales Growth
  • 4.5 Europe Sabin Inactivated Polio vaccine (sIPV) Sales Growth
  • 4.6 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Growth

5 Americas

  • 5.1 Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Country
    • 5.1.1 Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2017-2022)
    • 5.1.2 Americas Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2017-2022)
  • 5.2 Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Type
  • 5.3 Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Region
    • 6.1.1 APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2017-2022)
    • 6.1.2 APAC Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2017-2022)
  • 6.2 APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Type
  • 6.3 APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Sabin Inactivated Polio vaccine (sIPV) by Country
    • 7.1.1 Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2017-2022)
    • 7.1.2 Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2017-2022)
  • 7.2 Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Type
  • 7.3 Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) by Country
    • 8.1.1 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Type
  • 8.3 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Sabin Inactivated Polio vaccine (sIPV)
  • 10.3 Manufacturing Process Analysis of Sabin Inactivated Polio vaccine (sIPV)
  • 10.4 Industry Chain Structure of Sabin Inactivated Polio vaccine (sIPV)

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Sabin Inactivated Polio vaccine (sIPV) Distributors
  • 11.3 Sabin Inactivated Polio vaccine (sIPV) Customer

12 World Forecast Review for Sabin Inactivated Polio vaccine (sIPV) by Geographic Region

  • 12.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Size Forecast by Region
    • 12.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Forecast by Region (2023-2028)
    • 12.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Sabin Inactivated Polio vaccine (sIPV) Forecast by Type
  • 12.7 Global Sabin Inactivated Polio vaccine (sIPV) Forecast by Application

13 Key Players Analysis

  • 13.1 Biokangtai
    • 13.1.1 Biokangtai Company Information
    • 13.1.2 Biokangtai Sabin Inactivated Polio vaccine (sIPV) Product Offered
    • 13.1.3 Biokangtai Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Biokangtai Main Business Overview
    • 13.1.5 Biokangtai Latest Developments
  • 13.2 Sinovac
    • 13.2.1 Sinovac Company Information
    • 13.2.2 Sinovac Sabin Inactivated Polio vaccine (sIPV) Product Offered
    • 13.2.3 Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Sinovac Main Business Overview
    • 13.2.5 Sinovac Latest Developments
  • 13.3 Imbcams
    • 13.3.1 Imbcams Company Information
    • 13.3.2 Imbcams Sabin Inactivated Polio vaccine (sIPV) Product Offered
    • 13.3.3 Imbcams Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Imbcams Main Business Overview
    • 13.3.5 Imbcams Latest Developments
  • 13.4 Intravacc
    • 13.4.1 Intravacc Company Information
    • 13.4.2 Intravacc Sabin Inactivated Polio vaccine (sIPV) Product Offered
    • 13.4.3 Intravacc Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Intravacc Main Business Overview
    • 13.4.5 Intravacc Latest Developments
  • 13.5 Beijing Biological
    • 13.5.1 Beijing Biological Company Information
    • 13.5.2 Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Product Offered
    • 13.5.3 Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Beijing Biological Main Business Overview
    • 13.5.5 Beijing Biological Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Sabin Inactivated Polio vaccine (sIPV). Industry analysis & Market Report on Sabin Inactivated Polio vaccine (sIPV) is a syndicated market report, published as Global Sabin Inactivated Polio vaccine (sIPV) Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Sabin Inactivated Polio vaccine (sIPV) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,650.00
$7,320.00
2,930.95
5,877.96
3,427.35
6,873.48
564,071.00
1,131,232.80
305,067.00
611,805.60
Credit card Logo
Sample Question Discount Download PDF

Related Reports

Reason to Buy

  • Trusted By Leaders

    Top executives from leading companies purchase research reports from us. 

  • Shop With Confidence

    We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

  • Customer Centric

    Need assistance related to your research requirements? We are just a phone call or an email away.

  • Personalized Solutions

    Our experienced research specialists are here to help you locate the right reports for your need.

  • Secure Checkout

    Shop without being worried about safety & security of your transactions.
    •

Request for Sample of this report

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo